Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Curr Cancer Drug Targets. 2018;18(9):905–911. doi: 10.2174/1568009617666170808105633

Figure 1. Inhibition of AR prevents HFD-induced polyp formation in the small intestines of ApcMin/+ mice.

Figure 1

ApcMin/+ mice were divided into three groups: (i) control; (ii) HFD and (iii) HFD + fidarestat (50 mg/kg body wt, in drinking water) as described in the Methods. Mice were euthanized after 12 weeks and small intestines were stained and examined for polyp formation. A) Number of intestinal polyps and B) size of the intestinal polyps were determined by staining the intestines with methylene blue. Data represents mean ± SEM (n= 6–7); *P=0.001, #P= 0.0428, *P= 0.0375, ##P= 0.007, HFD alone vs HFD + Fid. Con, control; HFD, high fat diet; HFD + Fid, high fat diet + fidarestat.